Matches in Nanopublications for { <http://www.nextprot.org/nanopubs#NX_Q8IXJ6-5_MUTAGEN_298_298.RAW3OPgCIpqUhnPYpdUSG6SuKI9PyBLcg6S6i-afEeLg0._1> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- NX_Q8IXJ6-5_MUTAGEN_298_298.RAW3OPgCIpqUhnPYpdUSG6SuKI9PyBLcg6S6i-afEeLg0._1 type RangedSequencePosition NX_Q8IXJ6-5_MUTAGEN_298_298.RAW3OPgCIpqUhnPYpdUSG6SuKI9PyBLcg6S6i-afEeLg0.assertion.
- NX_Q8IXJ6-5_MUTAGEN_298_298.RAW3OPgCIpqUhnPYpdUSG6SuKI9PyBLcg6S6i-afEeLg0._1 type SO_0001148 NX_Q8IXJ6-5_MUTAGEN_298_298.RAW3OPgCIpqUhnPYpdUSG6SuKI9PyBLcg6S6i-afEeLg0.assertion.
- NX_Q8IXJ6-5_MUTAGEN_298_298.RAW3OPgCIpqUhnPYpdUSG6SuKI9PyBLcg6S6i-afEeLg0._1 comment "Does not affect deacetylase activity. Abolishes CDK2-dependent phosphorylation. Inhibits cellular proliferation delay in the early metaphase to prevent chromosomal instability. Does not inhibit interaction with a cyclin E-CDK2 complex. Does not inhibit interaction with HDAC6 and ubiquitination. Inhibits cell adhesion and migration and neurite outgrowth. Inhibits deacetylase activity; when associated with A-372." NX_Q8IXJ6-5_MUTAGEN_298_298.RAW3OPgCIpqUhnPYpdUSG6SuKI9PyBLcg6S6i-afEeLg0.assertion.
- NX_Q8IXJ6-5_MUTAGEN_298_298.RAW3OPgCIpqUhnPYpdUSG6SuKI9PyBLcg6S6i-afEeLg0._1 SIO_000053 NX_Q8IXJ6-5_MUTAGEN_298_298.RAW3OPgCIpqUhnPYpdUSG6SuKI9PyBLcg6S6i-afEeLg0._2 NX_Q8IXJ6-5_MUTAGEN_298_298.RAW3OPgCIpqUhnPYpdUSG6SuKI9PyBLcg6S6i-afEeLg0.assertion.
- NX_Q8IXJ6-5_MUTAGEN_298_298.RAW3OPgCIpqUhnPYpdUSG6SuKI9PyBLcg6S6i-afEeLg0._1 SIO_000053 NX_Q8IXJ6-5_MUTAGEN_298_298.RAW3OPgCIpqUhnPYpdUSG6SuKI9PyBLcg6S6i-afEeLg0._3 NX_Q8IXJ6-5_MUTAGEN_298_298.RAW3OPgCIpqUhnPYpdUSG6SuKI9PyBLcg6S6i-afEeLg0.assertion.